- Home
- PACK vs AQST Comparison
PACK vs AQST Comparison
Compare PACK & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACK
- AQST
- Stock Information
- Founded
- PACK 1972
- AQST 2004
- Country
- PACK United States
- AQST United States
- Employees
- PACK N/A
- AQST 142
- Industry
- PACK Containers/Packaging
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- PACK Consumer Discretionary
- AQST Health Care
- Exchange
- PACK Nasdaq
- AQST Nasdaq
- Market Cap
- PACK 313.3M
- AQST 390.4M
- IPO Year
- PACK N/A
- AQST 2018
- Fundamental
- Price
- PACK $4.01
- AQST $3.95
- Analyst Decision
- PACK Buy
- AQST Strong Buy
- Analyst Count
- PACK 2
- AQST 7
- Target Price
- PACK $5.50
- AQST $11.29
- AVG Volume (30 Days)
- PACK 294.4K
- AQST 1.1M
- Earning Date
- PACK 08-08-2025
- AQST 08-05-2025
- Dividend Yield
- PACK N/A
- AQST N/A
- EPS Growth
- PACK N/A
- AQST N/A
- EPS
- PACK N/A
- AQST N/A
- Revenue
- PACK $374,800,000.00
- AQST $54,228,000.00
- Revenue This Year
- PACK $9.69
- AQST N/A
- Revenue Next Year
- PACK $8.27
- AQST $51.62
- P/E Ratio
- PACK N/A
- AQST N/A
- Revenue Growth
- PACK 10.11
- AQST 5.29
- 52 Week Low
- PACK $2.91
- AQST $2.12
- 52 Week High
- PACK $9.04
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- PACK 61.35
- AQST 53.75
- Support Level
- PACK $3.85
- AQST $3.85
- Resistance Level
- PACK $4.12
- AQST $4.10
- Average True Range (ATR)
- PACK 0.14
- AQST 0.23
- MACD
- PACK 0.03
- AQST -0.06
- Stochastic Oscillator
- PACK 78.57
- AQST 15.20
About PACK Ranpak Holdings Corp
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.